Brief: Transmedics Provides Information On Impact Of Release Of Valuation Allowance On Deferred Tax Assets On Previously Reported Quarterly Results
27/02/2026 12:14
Feb 27 (Reuters) - Transmedics Group Inc TMDX.O: TRANSMEDICS PROVIDES ADDITIONAL INFORMATION ON THE IMPACT OF THE RELEASE OF THE VALUATION ALLOWANCE ON DEFERRED TAX ASSETS ON PREVIOUSLY REPORTED FOURTH QUARTER FINANCIAL RESULTS Source text: ID:nPn97K6jVa Further company coverage: TMDX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on TransMedics
See all newsBrief: TransMedics Appoints Fernando Araujo As Chief Financial Officer And Reiterates 2026 Financial Outlook
Transmedics Group Inc reports results for the quarter ended June 30 - Earnings Summary
TransMedics Q2 net income declines on R&D and infrastructure expenses
Brief: Transmedics Group Q2 EPS USD 0.41
TransMedics Q1 revenue edges past estimates